766 related articles for article (PubMed ID: 17051250)
21. A tightly regulated and reversibly inducible siRNA expression system for conditional RNAi-mediated gene silencing in mammalian cells.
Wu RH; Cheng TL; Lo SR; Hsu HC; Hung CF; Teng CF; Wu MP; Tsai WH; Chang WT
J Gene Med; 2007 Jul; 9(7):620-34. PubMed ID: 17486668
[TBL] [Abstract][Full Text] [Related]
22. Herpes simplex virus RNAi and neprilysin gene transfer vectors reduce accumulation of Alzheimer's disease-related amyloid-beta peptide in vivo.
Hong CS; Goins WF; Goss JR; Burton EA; Glorioso JC
Gene Ther; 2006 Jul; 13(14):1068-79. PubMed ID: 16541122
[TBL] [Abstract][Full Text] [Related]
23. Targeting HSV amplicon vectors.
Grandi P; Spear M; Breakefield XO; Wang S
Methods; 2004 Jun; 33(2):179-86. PubMed ID: 15121173
[TBL] [Abstract][Full Text] [Related]
24. Comparative analysis of genomic HSV vectors for gene delivery to motor neurons following peripheral inoculation in vivo.
Perez MC; Hunt SP; Coffin RS; Palmer JA
Gene Ther; 2004 Jul; 11(13):1023-32. PubMed ID: 15164091
[TBL] [Abstract][Full Text] [Related]
25. Optimization of an siRNA-expression system with an improved hairpin and its significant suppressive effects in mammalian cells.
Miyagishi M; Sumimoto H; Miyoshi H; Kawakami Y; Taira K
J Gene Med; 2004 Jul; 6(7):715-23. PubMed ID: 15241778
[TBL] [Abstract][Full Text] [Related]
26. Intracellular-diced dsRNA has enhanced efficacy for silencing HCV RNA and overcomes variation in the viral genotype.
Watanabe T; Sudoh M; Miyagishi M; Akashi H; Arai M; Inoue K; Taira K; Yoshiba M; Kohara M
Gene Ther; 2006 Jun; 13(11):883-92. PubMed ID: 16496015
[TBL] [Abstract][Full Text] [Related]
27. Drug delivery of siRNA therapeutics: potentials and limits of nanosystems.
Reischl D; Zimmer A
Nanomedicine; 2009 Mar; 5(1):8-20. PubMed ID: 18640078
[TBL] [Abstract][Full Text] [Related]
28. Effective gene suppression using small interfering RNA in hard-to-transfect human T cells.
Yin J; Ma Z; Selliah N; Shivers DK; Cron RQ; Finkel TH
J Immunol Methods; 2006 May; 312(1-2):1-11. PubMed ID: 16603179
[TBL] [Abstract][Full Text] [Related]
29. Complete knockdown of CCR5 by lentiviral vector-expressed siRNAs and protection of transgenic macrophages against HIV-1 infection.
Anderson J; Akkina R
Gene Ther; 2007 Sep; 14(17):1287-97. PubMed ID: 17597795
[TBL] [Abstract][Full Text] [Related]
30. Interference of porcine reproductive and respiratory syndrome virus replication on MARC-145 cells using DNA-based short interfering RNAs.
He YX; Hua RH; Zhou YJ; Qiu HJ; Tong GZ
Antiviral Res; 2007 May; 74(2):83-91. PubMed ID: 16730075
[TBL] [Abstract][Full Text] [Related]
31. Selection and validation of optimal siRNA target sites for RNAi-mediated gene silencing.
Luo Q; Kang Q; Song WX; Luu HH; Luo X; An N; Luo J; Deng ZL; Jiang W; Yin H; Chen J; Sharff KA; Tang N; Bennett E; Haydon RC; He TC
Gene; 2007 Jun; 395(1-2):160-9. PubMed ID: 17449199
[TBL] [Abstract][Full Text] [Related]
32. In vivo gene transfer to the rat retina using herpes simplex virus type 1 (HSV-1)-based amplicon vectors.
Fraefel C; Mendes-Madeira A; Mabon O; Lefebvre A; Le Meur G; Ackermann M; Moullier P; Rolling F
Gene Ther; 2005 Aug; 12(16):1283-8. PubMed ID: 15889134
[TBL] [Abstract][Full Text] [Related]
33. Delivery of herpes simplex virus vectors through liposome formulation.
Fu X; Zhang X
Mol Ther; 2001 Nov; 4(5):447-53. PubMed ID: 11708881
[TBL] [Abstract][Full Text] [Related]
34. Maintaining inhibition: siRNA double expression vectors against coxsackieviral RNAs.
Schubert S; Grunert HP; Zeichhardt H; Werk D; Erdmann VA; Kurreck J
J Mol Biol; 2005 Feb; 346(2):457-65. PubMed ID: 15670596
[TBL] [Abstract][Full Text] [Related]
35. Inhibition of hepatitis C virus gene expression by small interfering RNAs using a tri-cistronic full-length viral replicon and a transient mouse model.
Kim M; Shin D; Kim SI; Park M
Virus Res; 2006 Dec; 122(1-2):1-10. PubMed ID: 16979254
[TBL] [Abstract][Full Text] [Related]
36. Generation of stable retrovirus packaging cell lines after transduction with herpes simplex virus hybrid amplicon vectors.
Sena-Esteves M; Hampl JA; Camp SM; Breakefield XO
J Gene Med; 2002; 4(3):229-39. PubMed ID: 12112640
[TBL] [Abstract][Full Text] [Related]
37. Novel methods for expressing RNA interference in human cells.
Sano M; Kato Y; Akashi H; Miyagishi M; Taira K
Methods Enzymol; 2005; 392():97-112. PubMed ID: 15644177
[TBL] [Abstract][Full Text] [Related]
38. HIV-1-specific RNA interference.
Boden D; Pusch O; Ramratnam B
Curr Opin Mol Ther; 2004 Aug; 6(4):373-80. PubMed ID: 15468596
[TBL] [Abstract][Full Text] [Related]
39. Establishment of a novel foreign gene delivery system combining an HSV amplicon with an attenuated replication-competent virus, HSV-1 HF10.
Zhang L; Daikoku T; Ohtake K; Ohtsuka J; Nawa A; Kudoh A; Iwahori S; Isomura H; Nishiyama Y; Tsurumi T
J Virol Methods; 2006 Nov; 137(2):177-83. PubMed ID: 16854473
[TBL] [Abstract][Full Text] [Related]
40. Materializing the potential of small interfering RNA via a tumor-targeting nanodelivery system.
Pirollo KF; Rait A; Zhou Q; Hwang SH; Dagata JA; Zon G; Hogrefe RI; Palchik G; Chang EH
Cancer Res; 2007 Apr; 67(7):2938-43. PubMed ID: 17409398
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
